• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Gastro-enteropancreatic Neuroendocrine Tumor

Gastro-enteropancreatic Neuroendocrine Tumor - 18 Studies Found

Active, not recruiting : Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
: Gastroenteropancreatic Neuroendocrine Tumors
: 2014-09-02
:
  • Drug: Lanreotide Autogel 120 mg

Completed : 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
: Gastroenteropancreatic Neuroendocrine Tumors
: 2014-06-03
: Drug: 68Ga-OPS202
Completed : 177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs
: Gastroenteropancreatic Neuroendocrine Tumors
: 2013-04-25
: Drug: Intravenous injection of 177Lu-octreotate Treatment will consist of 177Lu-octreotate injections in
Completed : Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
: Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
: 2010-12-16
:
  • Drug: Pasireotide LAR followed by Pasireotide LAR + Everolimus

Not yet recruiting : TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors
:
  • Neuroendocrine Tumors
  • Neuroendocrine Carcinoma
  • Temozolomid
    : 2017-03-09
    : Drug: TEMCAP Oral capecitabine 750 mg/m2 twice a day, Day 1 to 14 and oral temozolomide 200 mg/m2 once a
Completed : Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
:
  • Gastroenteropancreatic Neuroendocrine Tumor
  • Lung Neuroendocrine
    : 2016-10-27
    : Procedure: NETest 5 mL of blood will be drawn from participants for testing.
Active, not recruiting : The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
:
  • Gastro-enteropancreatic Neuroendocrine Tumor
  • Secondary Malignan
    : 2011-08-24
    : Other: magnetic resonance imaging (MRI) Each patient will
COMPLETED : A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly
: Gastro-enteropancreatic Neuroendocrine Tumor
: 2025-09-03
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.